Search Results (103)

Bone tissue plays a vital role in the human body and possesses intrinsic self-repair mechanisms; however, large defects or pathological fractures may exceed its natural healing capacity. Bone tissue engineering provides promising strategies to restore bone integrity through the use of scaffolds, growth factors, and stem cells. While calcium phosphate (CaP)-based ceramics, such as hydroxyapatite (HAp) and tricalcium phosphate (TCP), represent the current benchmark, their limitations, including slow degradation (HAp) and limited osteoinductivity (TCP), have driven the development of alternative biomaterials. In this context, magnesium phosphate (MgP)-based materials have gained increasing attention due to their tunable resorption rate, improved biodegradability, and ability to stimulate osteogenesis and angiogenesis through the release of magnesium (Mg²⁺) ions. This study reports on composite scaffolds based on electrospun poly(ε-caprolactone) (PCL) fibres coated with MgP layers doped with lithium (Li) and zinc (Zn), designed to mimic the nanofibrous architecture of the extracellular matrix. Lithium and zinc were selected due to their known ability to modulate cellular response, with lithium promoting osteogenic activity and zinc contributing to improved cell proliferation and antibacterial potential. The phosphate phases obtained by coprecipitation were deposited onto the PCL fibres using Matrix-Assisted Pulsed Laser Evaporation (MAPLE), enabling controlled surface functionalization. Following thermal treatment, the formation of the crystalline magnesium pyrophosphate (Mg₂P₂O₇) phase was confirmed by chemical and structural characterization. The combination of a slowly degrading PCL matrix, providing sustained structural support, and a bioactive MgP coating, enabling rapid and controlled ion release, results in improved scaffold performance in terms of biocompatibility, biodegradability, and bioactivity. While the slow degradation rate of PCL ensures mechanical stability over an extended period, the surface-deposited MgP phase allows immediate interaction with the biological environment, facilitating faster ion release and enhancing cell–material interactions. These findings highlight the potential of the developed composites as promising candidates for trabecular bone regeneration and as viable alternatives to conventional CaP-based scaffolds in regenerative medicine. Full article

There has been much development of composites of calcium phosphate and polymers for use as artificial bone, with other applications still ongoing, and clarification of the in vivo absorption mechanism is considered an important perspective. In order to clarify the absorption mechanism of bioabsorbable materials used for artificial bones and bone grafts, we prepared composites of calcium phosphate and polymers and conducted in vivo experiments in experimental animals using composites as implantation samples. Two typical types of calcium phosphate, β-tricalcium phosphate (β-TCP) and unsintered hydroxyapatite (uHA), were used as calcium phosphate, and copolymers of poly-dl-lactide-co-glycolide (PDLGA) and poly-l-lactide-co-glycolide (PLGA) were used as polymers. For samples composed of PDLGA and calcium phosphates, the weight ratios of calcium phosphate were set at 40% and 10% for uHA and 40% for β-TCP (uHA(40), uHA(10) and β-TCP(40), respectively). A composite sample of PLGA and uHA was also prepared with a weight ratio of 10% uHA (uHA(10)/PLGA), intending slow degradation of the polymer matrix compared to PDLGA. The samples were implanted in the metaphysis and diaphysis region of rabbits’ femur for up to 48 weeks. In this study, positron emission tomography/X-ray computed tomography (PET/CT) was used to continuously evaluate the changes in the samples and the accumulation of cells in the animals, and histological evaluation was performed, focusing on the time of characteristic changes in the PET/CT to confirm the cell types. The results are summarized as follows: (1) the absorption mechanism of the materials used in this study was suggested to be mainly phagocytosis by macrophages; (2) the disappearance rate was faster for β-TCP(40) compared with uHA(40); and (3) uHA(10), having a lower proportion of uHA, is not prone to aggregation and exhibited a similar disappearance result to β-TCP(40). These results suggest that phagocytosis by macrophages is the dominant path in resorption of the bioresorbable materials, and the resorption period varies depending on the type of polymer. It is important to optimize the type and amount of polymers and calcium phosphate in order to achieve a degradation rate of bioresorbable materials that corresponds to the extent of damage in the healing area. Full article

Shape-memory polymers (SMPs) are a class of smart materials capable of recovering their original shape from a programmed temporary shape in response to external stimuli such as heat, light, or magnetic fields. SMPs have attracted significant interest for biomedical devices and soft robotics due to their large recoverable strains, programmable mechanical and thermal properties, tunable activation temperatures, responsiveness to various stimuli, low density, and ease of processing via additive manufacturing techniques, as well as demonstrated biocompatibility and potential bioresorbability. This review summarises recent progress in the fundamentals, classification, activation mechanisms, and fabrication strategies of SMPs, focusing particularly on design principles that influence performance relevant to specific applications. Both thermally and non-thermally activated SMP systems are discussed, alongside methods for controlling activation temperatures, including plasticisation, copolymerisation, and modulation of cross-linking density. The use of functional nanofillers to enhance thermal and electrical conductivity, mechanical strength, and actuation efficiency is also considered. Current manufacturing techniques are critically evaluated in terms of resolution, material compatibility, scalability, and integration potential. Biodegradable SMPs are highlighted, with discussion of degradation behaviour, biocompatibility, and demonstrations in devices such as haemostatic foams, embolic implants, and bone scaffolds. However, despite their promising potential, the widespread application of SMPs faces several challenges, including non-uniform activation, the need to balance mechanical strength with shape recovery, and limited standardisation. Addressing these issues is critical for advancing SMPs from laboratory research to clinical and industrial applications. Full article

Background/Objectives: Biodegradable implants have emerged as a promising alternative to traditional metallic fixation devices in pediatric orthopedic surgery. Avoiding implant removal is especially advantageous in children, who would otherwise require a second operation with additional anesthetic and surgical risks. This study reviews the current use of poly(lactic-co-glycolic acid) (PLGA) implants in pediatric fracture fixation and evaluates how they address limitations associated with traditional hardware. Methods: A narrative review was conducted summarizing current evidence, clinical experience, and case examples involving PLGA-based devices used in pediatric trauma. Special emphasis was placed on the degradation mechanism of PLGA, its controlled hydrolysis profile, and the capacity of the material to provide temporary mechanical stability during bone healing before complete resorption. The review included studies of PLGA use in forearm, distal radius, ankle, and elbow fractures, comparing outcomes to those obtained with metallic implants. Results: Across multiple clinical reports and case series, PLGA implants demonstrated effective fracture healing, stable fixation, and complication rates comparable to traditional metallic devices. Patients treated with resorbable implants benefited from reduced postoperative morbidity, no requirement for implant removal, and improved imaging compatibility. Conclusions: PLGA-based bioabsorbable implants represent a safe and effective alternative to conventional metal fixation in children. Their favorable degradation kinetics and clinical performance support their growing use in pediatric trauma surgery, while ongoing advances in polymer design and bioresorbable alloys continue to expand future applications. Full article

Over the past decades, coronary revascularization has evolved dramatically with the introduction of bioresorbable scaffolds (BRSs), designed to provide temporary vessel support, elute antiproliferative drugs, and then fully resorb, ideally restoring natural vasomotion and eliminating long-term foreign-body reactions. Early enthusiasm for first-generation polymeric devices, such as the Absorb bioresorbable vascular scaffold, was tempered by increased rates of scaffold thrombosis and late adverse events, largely attributed to thick struts, suboptimal implantation techniques, and unpredictable degradation kinetics. Subsequent developments in polymeric (e.g., MeRes-100, NeoVas) and metallic magnesium-based scaffolds (e.g., Magmaris) have focused on thinner struts, improved radial strength, and refined resorption profiles. Clinical trials and meta-analyses, including ABSORB, AIDA, BIOSOLVE, and BIOSTEMI, reveal that optimized procedural strategies, especially the “PSP” approach (Prepare–Size–Post-dilate) and routine intravascular imaging, substantially reduce thrombosis and restenosis rates, aligning outcomes closer to those of contemporary drug-eluting stents (DESs). Nonetheless, challenges persist regarding inflammatory responses to degradation by-products, mechanical fragility in complex lesions, and patient selection. Ongoing innovations include hybrid polymer–metal designs, stimuli-responsive drug coatings, and AI-assisted imaging for precision implantation. While early-generation BRSs demonstrated both promise and pitfalls, next-generation platforms show steady progress toward achieving the dual goals of transient scaffolding and long-term vessel restoration. The current trajectory suggests that bioresorbable technology, supported by optimized technique and material science, may soon fulfill its original vision; offering safe, effective, and fully resorbable alternatives to permanent metallic stents in coronary artery disease. This review provides an updated synthesis of the design principles, clinical outcomes, and procedural considerations of drug-eluting bioresorbable scaffolds (BRSs). It integrates recent meta-analytic evidence and emerging insights on device mechanics, including the influence of strut thickness on radial strength and the potential role of non-invasive imaging in pre-implantation planning. Special focus is given to magnesium-based scaffolds and future directions in patient selection and implantation strategy. Full article

Implantable drug delivery devices may enhance therapeutic efficacy by allowing localized drug release, and they may overcome the drawbacks of conventional systemic treatment. Electrospun nanofibers are promising drug delivery systems due to their high surface-to-volume ratio, porosity, and easy drug encapsulation. However, controlled and sustained drug release is required to improve therapeutic efficacy and reduce toxicity. Also, the ability to tailor the release drug dose would be a useful tool for providing an optimal and individualized approach for the treatment. Therefore, the aim of the study was to analyze the possibility to tailor the release of paclitaxel (PTX) from poly(D,L-lactide-co-glycolide) (PDLGA) electrospun nonwovens by modifying the comonomer molar ratio. For this purpose, three kinds of polymers were compared with lactidyl-to-glycolidyl comonomer ratios of 86:14, 70:30, and 48:52. Also, nonwovens obtained from a blend of PDLGA and PVA were used to analyze the effect of the addition of the hydrophilic polymer on degradation and, thus, the release rate. The comprehensive analysis of the developed nonwovens was conducted through an evaluation of the morphology, in vitro degradation, and drug release process, as well as cytotoxicity. It has been observed that all kinds of the developed PDLGA nonwovens provide an extended-release profile but with different release rates, which depend on the comonomer unit ratio and molar mass of the copolymer. Moreover, the increase in hydrophilicity caused by PVA sufficiently accelerates PTX release. The biological activity of released PTX was confirmed under in vitro and in vivo conditions against 4T1 mouse mammary carcinoma. The results of the study enabled us to gain insight into the influence of polymer choice on PTX release from PDLGA ES implants, which may be helpful in their easier translation into the clinic and for better adjustment of the PTX dose for individual treatment. Full article

Hydrothermal treatment was investigated as a strategy to enhance the supercritical CO₂ foaming process for the fabrication of polycaprolactone (PCL) scaffolds intended for tissue engineering applications. PCL samples were subjected to supercritical foaming at 300 bar and 40 °C for 60 min, combined with hydrothermal treatments performed either before or after foaming at temperatures of 70–100 °C and pressures of 10–20 bar. The effects of these treatments on scaffold morphology, porosity, and mechanical behavior were evaluated using scanning electron microscopy, micro-computed tomography, and compression testing. The results showed that hydrothermal treatment prior to foaming significantly improved scaffold porosity from 16.5% (untreated PCL) up to 57.9% while increasing pore interconnectivity (up to 156.8 throats mm⁻³). Conversely, post-foaming hydrothermal treatment led to pore collapse and loss of structural integrity. The pre-treated scaffolds maintained compressive moduli within 2–12 MPa, consistent with values required for bone tissue engineering. In vitro degradation in PBS revealed a moderate increase in weight loss (~10% after 90 days), indicating that the hydrothermal step slightly accelerates polymer hydrolysis without compromising stability. These findings demonstrate that combining hydrothermal pre-treatment with supercritical CO₂ foaming provides a solvent-free route to tailor scaffold morphology and mechanical performance, offering a sustainable alternative for the design of bioresorbable materials in regenerative medicine. Full article

Finite element analysis (FEA) is common in biomedical engineering for combining design and material development, with model validation crucial for accurate prediction of material behavior. Simplified geometries are commonly needed in stent development due to high effort in prototype manufacturing. This study outlines a methodology for FEA validation related to stent development-related FEA validation using injection-molded planar 2D substructures from a stent design with two types of polymers: poly(l-lactide) (PLLA) and poly(glycolide-co-trimethylene carbonate) (PGA-co-TMC). Specimens underwent quasi-static and cyclic testing, including loading, stress relaxation, unloading, and strain recovery. The material model coefficients for FEA were calibrated for three different constitutive models: linear elastic–plastic (LEP), Parallel Rheological Framework (PRF), and Three-Network (TN) model. The validation of planar stent segment expansion (PSSE) showed strong agreement with the experiments in deformation patterns, with varying force–displacement responses. The PRF and TN models provided better fits for behavioral predictions, with the PRF model being especially favorable for PLLA, while all models exhibited limitations for PGA-co-TMC. This study proposes a robust approach for the material modeling in stent development, enabling efficient material screening and stent design optimization through a simplified 2D validation setup. Material model accuracy depends strongly on calibration–load case congruence, while phenomenological approaches (PRF) show enhanced model robustness against load case variations compared to physically coupled models (TN). Full article

Biopolymers have emerged as a transformative class of materials that reconcile high-performance functionality with environmental stewardship. Their inherent capacity for controlled degradation and biocompatibility has driven rapid advancements across electronics, sensing, actuation, and healthcare. In flexible electronics, these polymers serve as substrates, dielectrics, and conductive composites that enable transient devices, reducing electronic waste without compromising electrical performance. Within sensing and actuation, biodegradable polymer matrices facilitate the development of fully resorbable biosensors and soft actuators. These systems harness tailored degradation kinetics to achieve temporal control over signal transduction and mechanical response, unlocking applications in in vivo monitoring and on-demand drug delivery. In healthcare, biodegradable polymers underpin novel approaches in tissue engineering, wound healing, and bioresorbable implants. Their tunable chemical architectures and processing versatility allow for precise regulation of mechanical properties, degradation rates, and therapeutic payloads, fostering seamless integration with biological environments. The convergence of these emerging applications underscores the pivotal role of biodegradable polymers in advancing sustainable technology and personalized medicine. Continued interdisciplinary research into polymer design, processing strategies, and integration techniques will accelerate commercialization and broaden the impact of these lower eCO₂ value materials across diverse sectors. This perspective article comments on the innovation in these sectors that go beyond the applications of biodegradable materials in packaging applications. Full article

A bioresorbable cannulated bone screw was developed using PLA/PCL-based composites reinforced with hydroxyapatite (HA) and titanium dioxide (TiO₂), two additives previously reported to enhance mechanical compliance, biocompatibility, and molding feasibility in biodegradable polymer systems. The design incorporated a crest-trimmed thread and a strategically positioned gate in the thin-wall zone opposite the hexagonal socket to preserve torque-transmitting geometry during micromolding. To investigate shrinkage behavior, a Taguchi orthogonal array was employed to systematically vary micromolding parameters, generating a structured dataset for training a back-propagation neural network (BPNN). Analysis of variance (ANOVA) identified melt temperature as the most influential factor affecting shrinkage quality, defined by a combination of shrinkage rate and dimensional variation. A hybrid AI framework integrating the BPNN with genetic algorithms and particle swarm optimization (GA–PSO) was applied to predict the optimal shrinkage conditions. This is the first use of BPNN–GA–PSO for cannulated bone screw molding, with the shrinkage rate as a targeted output. The AI-predicted solution, interpolated within the Taguchi design space, achieved improved shrinkage quality over all nine experimental groups. Beyond the specific PLA/PCL-based systems studied, the modeling framework—which combines geometry-specific gate design and normalized shrinkage prediction—offers broader applicability to other bioresorbable polymers and hollow implant geometries requiring high-dimensional fidelity. This study integrates composite formulation, geometric design, and data-driven modeling to advance the precision micromolding of biodegradable orthopedic devices. Full article

Poly(L-lactic acid) (PLLA) and iron (Fe) are popular bioresorbable material candidates for biomedical implants. However, PLLA coronary stents are relatively too thick compared to metallic stents when providing the same mechanical strength, while iron degrades too slowly. Recent studies show that PLLA coatings can enhance iron’s corrosion rate, and iron has strong mechanical strength, making PLLA–Fe composites ideal for bioresorbable implants. Although PLLA coatings on iron samples have been studied, research on embedding iron wires in relatively thick PLLA matrices is limited. Moreover, no studies have yet explored 3D-printed metal wire-reinforced PLLA monofilaments for biomedical applications. To address these research gaps and investigate the in vitro degradation profile of PLLA/Fe wire monofilaments for bioresorbable stents, this study first developed a novel polymer filament–metal wire coextrusion 3D printer for printing PLLA/Fe wire monofilaments. In vitro degradation tests were then conducted on both PLLA/Fe and neat PLLA monofilaments at 50 °C. Thereafter, characterizations, including mass loss, pH, surface appearance and morphology, tensile tests, gel permeation chromatography (GPC), and differential scanning calorimetry (DSC), were performed. Results indicated that the overall degradation rate of PLLA/Fe monofilaments was higher than that of PLLA counterparts, while the degradation rate of PLLA matrix was not affected by the embedded iron wire according to molecular weight analysis. Notably, the Young’s modulus and stiffness of PLLA monofilaments were significantly improved by the iron wires during the early stages of degradation, but the reinforcement in tensile strength was negative after immersion due to the poor embedding quality of the iron wires in the PLLA monofilaments. With future improvement of the embedding quality of iron wire, the 3D-printed PLLA/Fe wire composites can have great potential in the development of biomedical devices using the novel 3D printing method, including most types of stents and bone scaffolds. Full article

Restenosis is the main cause of failure after stent implantation during angioplasty. The localized, sustained delivery of an antirestenotic drug may reduce smooth muscle cell (SMCs) proliferation and thereby limit neointimal hyperplasia. The aim of this study was to develop degradable sirolimus-eluting polymer coatings that can be applied on bioresorbable polymer-based scaffolds via an ultrasonic coating system. This is a novel approach because the detailed analysis of the coating procedure on bioresorbable polymeric scaffolds with the use of an ultrasonic system has not been reported thus far. It has been observed that the ultrasonic technique facilitates formation of a smooth coating, well-integrated with the scaffold. However, the drug dose is affected by the concentration of the coating solution and the number of layers. Therefore, these parameters can be used for tailoring the drug dose and release process. Although all types of the developed coatings provided sirolimus elution for at least 3 months, a more uniform, diffusion-controlled release profile was observed from coatings obtained from the 1.0% polymeric solution. The released drug showed antiproliferative activity against vascular SMCs, without any hemolytic or thrombogenic effects. The results of the study may be advantageous for further progress in the development and medical translation of polymeric vascular scaffolds with antirestenotic activity. Full article

Coronary artery disease is the most common cause of mortality worldwide. Percutaneous coronary intervention represents an important method of treatment. Over time, the methods have been refined to improve safety and efficacy. With the development of drug-eluting stents, in-stent restenosis has importantly decreased, but it remains a relevant concern in terms of the need for additional revascularization procedures or recurrent coronary events. Different platforms, polymers, and anti-proliferative agents have been tested, mostly demonstrating non-inferiority when compared. Additional devices, such as drug-coated balloons, bioresorbable scaffold systems, gene-eluting stents and bioadaptor implants have been developed. As none of the aforementioned methods demonstrated considerable superiority over the others, the search for the ideal treatment method continues. Based on currently available data, the ideal treatment method could be a personalized approach combining different revascularization methods. Additional research with subpopulation group studies, different associated diseases or vessels affected, and longer follow-up are required to determine better subgroups of patients that would benefit most from specific treatment methods. Full article

The increasing demand for orthopedic and neurosurgical implants has driven advancements in biomaterials, additive manufacturing, and antimicrobial strategies. With an increasingly aging population, and a high incidence of orthopedic trauma in developing countries, the need for effective, biocompatible, and infection-resistant implants is more critical than ever. This review explores the role of polymers in 3D printing for medical applications, focusing on their use in orthopedic and neurosurgical implants. Polylactic acid (PLA), polycaprolactone (PCL), and polyetheretherketone (PEEK) have gained attention due to their biocompatibility, mechanical properties, and potential for antimicrobial modifications. A major challenge in implantology is the risk of periprosthetic joint infections (PJI) and surgical site infections (SSI). Current strategies, such as antibiotic-loaded polymethylmethacrylate (PMMA) spacers and bioactive coatings, aim to reduce infection rates, but limitations remain. Additive manufacturing enables the creation of customized implants with tailored porosity for enhanced osseointegration while allowing for the incorporation of antimicrobial agents. Future perspectives include the integration of artificial intelligence for implant design, nanotechnology for smart coatings, and bioresorbable scaffolds for improved bone regeneration. Advancing these technologies will lead to more efficient, cost-effective, and patient-specific solutions, ultimately reducing infection rates and improving long-term clinical outcomes. Full article

Laser micro-machining is a rapidly growing technique to create, manufacture and fabricate microstructures on different materials ranging from metals and ceramics to polymers. Micro- and nano-machining on different materials has been helpful and useful for various biomedical applications. This study focuses on the micro-machining of innovative barbed sutures using an ultrashort pulse laser, specifically a femtosecond (fs) laser system. Two bioresorbable polymeric materials, namely, catgut and poly (4-hydroxybutyrate) (P4HB), were studied and micro-machined using the femtosecond (fs) laser system. The optimized laser parameter was used to fabricate two different barb geometries, namely, straight and curved barbs. The mechanical properties were evaluated via tensile testing, and the anchoring performance was studied by means of a suture–tissue pull-out protocol using porcine dermis tissue which was harvested from the medial dorsal site. Along with the evaluation of the mechanical and anchoring properties, the thermal characteristics and degradation profiles were assessed and compared against mechanically cut barbed sutures using a flat blade. The mechanical properties of laser-fabricated barbed sutures were significantly improved when compared to the mechanical properties of the traditionally/mechanically cut barbed sutures, while there was not any significant difference in the anchoring properties of the barbed sutures fabricated through either of the fabrication techniques. Based on the differential scanning calorimetry (DSC) results for thermal transitions, there was no major impact on the inherent material properties due to the laser treatment. This was also observed in the degradation results, where both the mechanically cut and laser-fabricated barbed sutures exhibited similar profiles throughout the evaluation time period. It was concluded that switching the fabrication technique from mechanical cutting to laser fabrication would be beneficial in producing a more reproducible and consistent barb geometry with more precision and accuracy. Full article